510(k) K983699

MODIFICATION TO ABUSCREEN ONLINE FOR AMPHETAMINES by Roche Diagnostic Systems, Inc. — Product Code DKZ

K983699 is an FDA 510(k) premarket notification submitted by Roche Diagnostic Systems, Inc. for the device "MODIFICATION TO ABUSCREEN ONLINE FOR AMPHETAMINES". The FDA issued a decision of Substantially Equivalent on Dec 11, 1998. The device falls under product code DKZ (Enzyme Immunoassay, Amphetamine), a Class II device regulated under 21 CFR 862.3100. Roche Diagnostic Systems, Inc. has 295 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 11, 1998
Date Received
Oct 21, 1998
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Immunoassay, Amphetamine
Device Class
Class II
Regulation Number
862.3100
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Roche Diagnostic Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K983699. Report a data issue: hello@regdatalab.com.